Skip to content
Research Article Open access CC BY 3.0

Vaginal Mucosa – A Promising Site for Drug Therapy

Vinita Vijay Kale, Alok Ubgade

Journal of Pharmaceutical Research International · pp. 983–1000 · Published 21 Aug 2013

10.9734/BJPR/2013/3895

Abstract

The vagina provides a promising site for local effect as well as systemic drug delivery because of its large surface area, rich blood supply, avoidance of the first-pass effect, relatively high permeability to many drugs and self-insertion. The pharmaceuticals currently used for vaginal delivery includes those that provide protection against viral infections, including Acquired Immune Deficiency Syndrome (AIDS) and other sexually transmitted infection (STDs). The anti infectives used in treatment of vulvovaginal infection, and vaginitis includes chemicals, for example, clotrimazole, miconazole, clindamycin, sulfonamide and probiotics. Currently, there is a variety of pharmaceutical products available on the market designed for intravaginal therapy (tablets, creams, suppositories, pessaries, foams, solutions, ointments, intravaginal rings, films and gels). However, their efficacy is often limited by a poor retention at the site of action due to the self-cleansing action of the vaginal tract. The vaginal cell lining is covered with a viscous and elastic gel. The physicochemical properties of this gel can influence the rate of diffusion from the bulk to the site of absorption. The choice of absorption model depends totally on the questions to be answered with respect to the test compound being studied. Having studied this review, thus one should able to: understand the anatomy and physiology of the vagina as site of drug administration; understand the pharmaceuticals preferred for administration via vagina; understand the different vaginal delivery system; understand the in vitro models to study vaginal permeability.

Vaginal drug delivery vaginal epithelium permeability vaginal products evaluation of vaginal products vaginal infection microbiota of vagina.

Cited by 17

State of the art in intravaginal rings: from material engineering to 3D-printed multipurpose delivery systems.

José M. Trallero, Brayan J. Anaya, D. R. Serrano · Journal of Controlled Release · 2026

Vaginal Nanoformulations for the Management of Preterm Birth

Asad Mir, Richa Vartak, Ketan Patel · Pharmaceutics · 2022

Emerging Trends and Potential Prospects in Vaginal Drug Delivery.

S. Mahant, Abhishek Sharma, Himanshu Gandhi · Current Drug Delivery · 2022

Vaginal epithelial drug delivery.

Lana Matteucci, A. Holmes · Advanced Drug Delivery Reviews · 2022

Formulation and Evaluation of Vaginal Bioadhesive Drug Delivery System of Acyclovir

B. Mohite, Rakesh K. Patel, N. Kayande · Journal of Pharmaceutical Research International · 2021

Recent Advances in Polymer-Based Vaginal Drug Delivery Systems

T. Osmałek, A. Froelich, Barbara Jadach · Pharmaceutics · 2021

Chitosan nanoparticles as a potential drug delivery system attached to viscose cellulose fibers

Tijana Ristić, Andrej Zabret, L. F. Zemljič · Cellulose · 2017

Nanotechnological strategies for vaginal administration of drugs--a review.

P. D. da Silva, Matheus Aparecido dos Santos Ramos, B. V. Bonifácio · Journal of Biomedical Nanotechnology · 2014

Article metrics

Real usage data collected on this platform.

6

Page views

0

PDF downloads

0

Outbound clicks

17

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.